The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2018. The fund is constantly included in less than 2 deals per year.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Therapeutics, Medical. The fund has exact preference in some founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Kedalion Therapeutics, ViewPoint Therapeutics, Verana Health
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Lagunita BioSciences LLC, startups are often financed by Waycross Ventures, Mission Bay Capital, GE Ventures. The meaningful sponsors for the fund in investment in the same round are Mission Bay Capital, GE Ventures, Biomatics Capital Partners. In the next rounds fund is usually obtained by The Rise Fund, Novo Ventures, Mission Bay Capital.
Related Funds
Fund Name | Location |
Beijing Bohai Tongxin Private Equity Fund | Beijing, Beijing, China |
BitMEX | Beau Vallon, Mahé, Seychelles |
Elite Network | Japan, Tokyo |
Embarcadero Ventures | California, San Francisco, United States |
Huazhang Jiye Equity Investment Fund Management | China, Guangdong, Shenzhen |
Lower Silesian Intermediate Institution | - |
Meriten Investment Management | Germany, Saxony-Anhalt, Zehrental |
Montcalm Capital | California, San Francisco, United States |
Oval Park Capital | North Carolina, Raleigh, United States |
Revelstoke Capital Partners | Colorado, Denver, United States |
Riverfront Ventures | Pennsylvania, Pittsburgh, United States |
Robotunion | - |
Shengzhong Touzi | China, Chongqing, Yubei |
Sova | China, Huangpu, Shanghai |
Strata Equity Group | California, San Diego, United States |
Terra Nova Partners | - |
Vice Media | Brooklyn, New York, United States |
Xiamen Fenghuang Huaji | China, Fujian, Xiamen |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Kedalion Therapeutics | 15 Nov 2021 | California, United States | |||
Kedalion Therapeutics | $5M | 06 Aug 2018 | California, United States | ||
Verana Health | $30M | 31 Jul 2018 | San Francisco, California, United States | ||
ViewPoint Therapeutics | $35M | 05 Mar 2018 | San Francisco, California, United States | ||
ViewPoint Therapeutics | $4M | 05 May 2016 | San Francisco, California, United States | ||
Verana Health | $7M | 09 Feb 2015 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Kedalion Therapeutics | 15 Nov 2021 | California, United States | |||
Kedalion Therapeutics | $5M | 06 Aug 2018 | California, United States | ||
Verana Health | $30M | 31 Jul 2018 | San Francisco, California, United States | ||
ViewPoint Therapeutics | $35M | 05 Mar 2018 | San Francisco, California, United States | ||
ViewPoint Therapeutics | $4M | 05 May 2016 | San Francisco, California, United States | ||
Verana Health | $7M | 09 Feb 2015 | San Francisco, California, United States |